Auris Medical Announces Significant Inhibition of Tumor Growth with OligoPhore siRNA Targeting NF-κB in Murine Model of Adult T-Cell Leukemia / Lymphoma
June 21, 2021 08:30 ET
|
Auris Medical AG
Treatment with OligoPhoreTM siRNA stops aggressive ATLL tumor growth to near zeroSignificant reduction in tumor size, spleen size and peripheral blood lymphocyte countsResults add to extensive body of...
Magnetic Beads Market Size to Reach $2.6 Billion by 2027 | CAGR: 12.1%: AMR
March 28, 2021 19:50 ET
|
Allied Market Research
Portland, OR, March 28, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global magnetic beads market was pegged at $1.1 billion in 2019 and is estimated to...
Coverage Initiated for MCTC Holdings Inc. via NetworkNewsWire
November 21, 2019 08:30 ET
|
MCTC Holdings Inc. (d/b/a Cannabis Global)
NEW YORK, Nov. 21, 2019 (GLOBE NEWSWIRE) -- MCTC Holdings (OTC: MCTC), an innovator in the field of cannabinoid nanoparticles and infusion technologies, today announces it has selected the corporate...
Atlas Nanotech Opens First Revenue Stream
July 31, 2019 08:30 ET
|
COSTAS Inc.
GUADALAJARA, Mexico, July 31, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – CSSI (Costas Inc.), DBA Atlas Nanotech, today memorialized an agreement with Laboratorios Gem S.A. de C.V. of Mexico City...
Nanobiotix annonce la publication dans le Lancet Oncology des données de phase III dans le Sarcome des Tissus Mous pour NBTXR3 son produit premier d'une nouvelle classe
July 09, 2019 14:45 ET
|
Nanobiotix S.A.
NANOBIOTIX ANNONCE LA PUBLICATION DANS LE LANCET ONCOLOGY DES DONNÉES DE PHASE III DANS LE SARCOME DES TISSUS MOUS POUR NBTXR3 SON PRODUIT PREMIER D’UNE NOUVELLE CLASSE Les données...
Nanobiotix announces publication of phase III Soft Tissue Sarcoma data for first-in-class NBTXR3 in the Lancet Oncology
July 09, 2019 14:45 ET
|
Nanobiotix S.A.
NANOBIOTIX ANNOUNCES PUBLICATION OF PHASE III SOFT TISSUE SARCOMA DATA FOR FIRST-IN-CLASS NBTXR3 IN THE LANCET ONCOLOGY Previously reported data from the registration study (Act.In.Sarc)...
Nanobiotix annonce une nouvelle équipe de direction à la suite de son autorisation de mise sur le marché européen
July 01, 2019 02:00 ET
|
Nanobiotix S.A.
NANOBIOTIX ANNONCE UNE NOUVELLE ÉQUIPE DE DIRECTION À LA SUITE DE SON AUTORISATION DE MISE SUR LE MARCHÉ EUROPÉEN Récemment nommée Directeur Médical (CMO), le Dr Edwina...
Nanobiotix announces new organizational structure as the company enters its next stage after first european market approval
July 01, 2019 02:00 ET
|
Nanobiotix S.A.
NANOBIOTIX ANNOUNCES NEW ORGANIZATIONAL STRUCTURE AS THE COMPANY ENTERS ITS NEXT STAGE AFTER FIRST EUROPEAN MARKET APPROVAL Recently appointed Chief Medical Officer (CMO) Edwina Baskin-Bey, M.D.,...
Global Market for Nanocomposites to Reach $7.3 Billion by 2022
May 07, 2018 04:00 ET
|
BCC Research
WELLESLEY, Mass., May 07, 2018 (GLOBE NEWSWIRE) -- Technological advances are driving huge growth in the global market for nanocomposites. In a new report, Nanocomposites, Nanoparticles, Nanoclays...
Global Nanomedicine Market to Reach Nearly $300 Billion by 2022
October 11, 2017 10:30 ET
|
BCC Research
WELLESLEY, Mass., Oct. 11, 2017 (GLOBE NEWSWIRE) -- The use of nanotechnology in medical applications has the potential to revolutionize the way that diseases and injuries are treated. The...